MedDataX Logo

Tight Glycemic Control by Artificial Pancreas

NCT ID: NCT00657995

Last Updated: 2008-04-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

32 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-04-30

Study Completion Date

2007-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluated a closed-loop system providing continuous monitoring and strict control of perioperative blood glucose following pancreatic resection.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study recruited 32 patients undergoing elective pancreatic resection for pancreatic disease.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pancreatic Neoplasm

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

pancreatogenic diabetes artificial pancreas

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

2

Thirty patients who underwent pancreatic resection for pancreatic neoplasm were prospectively randomized. Perioperative blood glucose levels were continuously monitored using an artificial endocrine pancreas (STG-22). Glucose levels were controlled using either the sliding scale method or the artificial pancreas.

Group Type EXPERIMENTAL

Artificial Pancreas (STG-22)

Intervention Type DEVICE

safe tool

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Artificial Pancreas (STG-22)

safe tool

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

STG-22; NIKKISO Corporation, Japan

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* This study recruited 32 patients undergoing elective pancreatic resection for pancreatic disease.

Exclusion Criteria

* weight loss greater than 10% during the previous 6 months
* signs of distant metastasis
* respiratory, renal,or heart disease
* Patients provided written informed consent prior to enrollment
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kochi University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Kochi University

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Takehiro Okabayashi, MD

Role: STUDY_DIRECTOR

Kochi Medical School, Kochi University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kochi Medical School, Kochi University

Nankoku, Kohasu-Okocho, Japan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Japan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TGC-AP-01

Identifier Type: -

Identifier Source: org_study_id